Clinical Trial Update: Rh-endostatin Combined With Chemotherapy and Pembrolizumab for Advanced NSCLC [Phase 2]

View source ↗

Summary

Phase 2 trial examining rh-endostatin in combination with chemotherapy and pembrolizumab for advanced stage IV non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Chemotherapy (chemotherapy)
• Pembrolizumab (pembrolizumab)
• rh-endostatin (recombinant human endostatin)

Snippet

Sponsor: Guangzhou Institute of Respiratory Disease | Conditions: Staging IV NSCLC | Phase 2 | Status: UNKNOWN